Pharmacokinetics-Pharmacodynamics of Vancomycin

Sdílet
Vložit
  • čas přidán 24. 02. 2023
  • Learning objective 1. Explain the pharmacologic, pharmacokinetic, and pharmacodynamic properties of vancomycin.
    Learning objective 2. Determine a vancomycin loading dose for critically-ill patients with serious MRSA infections.
    Learning objective 3. Given a patient with a suspected MRSA infection, recommend IDSA guideline-concordant empiric vancomycin maintenance dose and frequency.
    Learning objective 4. Given a patient with a suspected MRSA infection, determine an empiric vancomycin maintenance dose and frequency based on population pharmacokinetics.
    Learning objective 5. Given a patient with an MRSA infection, select an individualized vancomycin dose and frequency based on serum vancomycin level.
    Learning objective 6. Given a patient on intermittent hemodialysis, recommend appropriate vancomycin dosing and monitoring.

Komentáře • 4

  • @anonymousperson2345
    @anonymousperson2345 Před měsícem

    💛

  • @sarehparavar8601
    @sarehparavar8601 Před 2 měsíci +1

    Great👍

  • @iindiar
    @iindiar Před 4 měsíci +2

    very thorough

  • @sarehparavar8601
    @sarehparavar8601 Před 2 měsíci

    When to measure the MIC ! Emprically? or even culture based ?bcoz actually our lab doesnt measure unless we request it ..
    another question .. our lab only measure trough so it means from trough i can not know the effectiveness of the vanco and change the dose or frequency from trough level like as old guideline do ? How i can get Auc:MIc then